Upadacitinib, Placebo for Upadacitinib, Upadacitinib clinical trials

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

This study is looking at a new medicine called Upadacitinib for teenagers and adults with moderate to severe eczema. It wants to see if the drug helps clear up skin and reduce itching better than a dummy pill.